Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

March 01, 2007; Volume 35,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ali, Shazia Y.

    1. You have access
      UDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme Kinetics
      Zhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
  2. Argikar, Upendra

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  3. Ariyoshi, Noritaka

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  4. Arkan, Melek C.

    1. You have access
      Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis
      Andrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. Cherrington
      Drug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
  5. Auerbach, Scott S.

    1. You have access
      CAR2 Displays Unique Ligand Binding and RXRα Heterodimerization Characteristics
      Scott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. Omiecinski
      Drug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641

B

  1. Ban, Masaaki

    1. You have access
      Involvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver Microsomes
      Takuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori Momose
      Drug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
  2. Barbier, Olivier

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  3. Bonzo, Jessica A.

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  4. Bowalgaha, K.

    1. You have access
      The Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7
      K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. Miners
      Drug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
  5. Brace-Sinnokrak, Erin

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  6. Bridges, Arlene S.

    1. You have access
      In Vitro and in Vivo Determination of Piperacillin Metabolism in Humans
      Giulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278
  7. Brouwer, Kim L. R.

    1. You have access
      In Vitro and in Vivo Determination of Piperacillin Metabolism in Humans
      Giulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278
  8. Bullock, Peter

    1. You have access
      Glucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species Differences
      Zhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815

C

  1. Cashman, John R.

    1. You have access
      Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation Activities
      Makiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi Yamazaki
      Drug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
  2. Chen, Shujuan

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  3. Cherrington, Nathan J.

    1. You have access
      Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis
      Andrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. Cherrington
      Drug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
  4. Courtney, Paul

    1. You have access
      The Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery Setting
      Charles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. Riley
      Drug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344

D

  1. DeKeyser, Joshua G.

    1. You have access
      CAR2 Displays Unique Ligand Binding and RXRα Heterodimerization Characteristics
      Scott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. Omiecinski
      Drug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641
  2. Djebli, Nassim

    1. You have access
      Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5
      Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre Marquet
      Drug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
  3. Dupuis, Robert E.

    1. You have access
      Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
      Stephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013

E

  1. Ekins, Sean

    1. You have access
      Classification of Metabolites with Kernel-Partial Least Squares (K-PLS)
      Mark J. Embrechts and Sean Ekins
      Drug Metabolism and Disposition March 2007, 35 (3) 325-327; DOI: https://doi.org/10.1124/dmd.106.013185
    2. You have access
      Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors
      Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
      Drug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
  2. Elliot, D. J.

    1. You have access
      The Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7
      K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. Miners
      Drug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
  3. Embrechts, Mark J.

    1. You have access
      Classification of Metabolites with Kernel-Partial Least Squares (K-PLS)
      Mark J. Embrechts and Sean Ekins
      Drug Metabolism and Disposition March 2007, 35 (3) 325-327; DOI: https://doi.org/10.1124/dmd.106.013185
  4. Endo, Takuro

    1. You have access
      Involvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver Microsomes
      Takuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori Momose
      Drug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425

F

  1. Fukami, Tatsuki

    1. You have access
      CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline
      Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
      Drug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064

G

  1. Gaus, Hans J.

    1. You have access
      Cross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100
      Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. Geary
      Drug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
  2. Geary, Richard S.

    1. You have access
      Cross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100
      Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. Geary
      Drug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
  3. Generaux, Claudia N.

    1. You have access
      In Vitro and in Vivo Determination of Piperacillin Metabolism in Humans
      Giulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278
  4. Ghibellini, Giulia

    1. You have access
      In Vitro and in Vivo Determination of Piperacillin Metabolism in Humans
      Giulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278
  5. Grime, Ken

    1. You have access
      The Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery Setting
      Charles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. Riley
      Drug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344

H

  1. Haefeli, Walter Emil

    1. You have access
      Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors
      Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil Haefeli
      Drug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
  2. Hara, Yoshiki

    1. You have access
      Involvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver Microsomes
      Takuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori Momose
      Drug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
  3. Harwood, H. James

    1. You have access
      Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors
      Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
      Drug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
  4. Hata, Masayuki

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  5. Hayashi, Yujiro

    1. You have access
      Characterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in Rodents
      Kazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
  6. Hirata, Kazuma

    1. You have access
      Involvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver Microsomes
      Takuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori Momose
      Drug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
  7. Hirayama, Masamichi

    1. You have access
      Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines
      Tomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi Tamai
      Drug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
  8. Hong, An

    1. You have access
      Cross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100
      Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. Geary
      Drug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
  9. Hoover, Dennis J.

    1. You have access
      Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors
      Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
      Drug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888

I

  1. Ishii, Itsuko

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304

J

  1. Jamei, Masoud

    1. You have access
      Misuse of the Well-Stirred Model of Hepatic Drug Clearance
      Jiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. Tucker
      Drug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
  2. Jie, Lu

    1. You have access
      Inhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious Rats
      Xin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-Xiang
      Drug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429

K

  1. Kaeding, Jenny

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  2. Kalvass, J. Cory

    1. You have access
      Pharmacokinetics and Pharmacodynamics of Alfentanil in P-Glycoprotein-Competent and P-Glycoprotein-Deficient Mice: P-Glycoprotein Efflux Alters Alfentanil Brain Disposition and Antinociception
      J. Cory Kalvass, Emily R. Olson and Gary M. Pollack
      Drug Metabolism and Disposition March 2007, 35 (3) 455-459; DOI: https://doi.org/10.1124/dmd.106.011445
  3. Karin, Michael

    1. You have access
      Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis
      Andrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. Cherrington
      Drug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
  4. Kato, Yukio

    1. You have access
      Functional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1
      Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira Tsuji
      Drug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
    2. You have access
      Characterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in Rodents
      Kazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
  5. Katoh, Miki

    1. You have access
      CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline
      Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
      Drug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
  6. Kazama, Emiko

    1. You have access
      Effect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus Monkeys
      Akihito Ogasawara, Toshiyuki Kume and Emiko Kazama
      Drug Metabolism and Disposition March 2007, 35 (3) 410-418; DOI: https://doi.org/10.1124/dmd.106.011288
  7. Ketabi-Kiyanvash, Nahal

    1. You have access
      Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors
      Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil Haefeli
      Drug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
  8. Kim, Tae-Won

    1. You have access
      Cross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100
      Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. Geary
      Drug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
  9. Kitada, Mitsukazu

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  10. Knights, K. M.

    1. You have access
      The Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7
      K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. Miners
      Drug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
  11. Kobayashi, Daisuke

    1. You have access
      Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines
      Tomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi Tamai
      Drug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
  12. Komoriya, Kazumi

    1. You have access
      Characterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in Rodents
      Kazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
  13. Kubo, Yoshiyuki

    1. You have access
      Functional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1
      Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira Tsuji
      Drug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
  14. Kume, Toshiyuki

    1. You have access
      Effect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus Monkeys
      Akihito Ogasawara, Toshiyuki Kume and Emiko Kazama
      Drug Metabolism and Disposition March 2007, 35 (3) 410-418; DOI: https://doi.org/10.1124/dmd.106.011288

L

  1. Lawton, Michael P.

    1. You have access
      Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors
      Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
      Drug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
  2. Lee, Kuo-Hsiung

    1. You have access
      Glucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species Differences
      Zhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
  3. Lickteig, Andrew J.

    1. You have access
      Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis
      Andrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. Cherrington
      Drug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
  4. Lindahl, Ronald

    1. You have access
      Constitutive and 3-Methylcholanthrene-Induced Rat ALDH3A1 Expression Is Mediated by Multiple Xenobiotic Response Elements
      Richard Reisdorph and Ronald Lindahl
      Drug Metabolism and Disposition March 2007, 35 (3) 386-393; DOI: https://doi.org/10.1124/dmd.106.012393
  5. Lindenmaier, Heike

    1. You have access
      Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors
      Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil Haefeli
      Drug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765

M

  1. Mackenzie, P. I.

    1. You have access
      The Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7
      K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. Miners
      Drug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
  2. Maeda, Tomoji

    1. You have access
      Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines
      Tomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi Tamai
      Drug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
  3. Mankowski, Dayna C.

    1. You have access
      Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors
      Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
      Drug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
  4. Marquet, Pierre

    1. You have access
      Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5
      Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre Marquet
      Drug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
  5. Martin, David E.

    1. You have access
      Glucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species Differences
      Zhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
  6. Miles, Kristini K.

    1. You have access
      Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
      Stephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
  7. Miners, J. O.

    1. You have access
      The Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7
      K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. Miners
      Drug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
  8. Mitsuoka, Keisuke

    1. You have access
      Functional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1
      Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira Tsuji
      Drug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
  9. Miyazawa, Keiji

    1. You have access
      Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines
      Tomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi Tamai
      Drug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
  10. Momose, Yasunori

    1. You have access
      Involvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver Microsomes
      Takuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori Momose
      Drug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
  11. Murayama, Norie

    1. You have access
      Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation Activities
      Makiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi Yamazaki
      Drug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094

N

  1. Nagashima, Satomi

    1. You have access
      Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation Activities
      Makiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi Yamazaki
      Drug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
  2. Nakajima, Miki

    1. You have access
      CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline
      Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
      Drug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
  3. Nakamura, Hiroyoshi

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  4. Nishigaki, Ryuichiro

    1. You have access
      Characterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in Rodents
      Kazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518

O

  1. O'Donnell, Charles J.

    1. You have access
      The Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery Setting
      Charles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. Riley
      Drug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
  2. Ogasawara, Akihito

    1. You have access
      Effect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus Monkeys
      Akihito Ogasawara, Toshiyuki Kume and Emiko Kazama
      Drug Metabolism and Disposition March 2007, 35 (3) 410-418; DOI: https://doi.org/10.1124/dmd.106.011288
  3. Ohmori, Shigeru

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  4. Ohsuye, Kazuhiro

    1. You have access
      Characterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in Rodents
      Kazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
  5. Olson, Emily R.

    1. You have access
      Pharmacokinetics and Pharmacodynamics of Alfentanil in P-Glycoprotein-Competent and P-Glycoprotein-Deficient Mice: P-Glycoprotein Efflux Alters Alfentanil Brain Disposition and Antinociception
      J. Cory Kalvass, Emily R. Olson and Gary M. Pollack
      Drug Metabolism and Disposition March 2007, 35 (3) 455-459; DOI: https://doi.org/10.1124/dmd.106.011445
  6. Omiecinski, Curtis J.

    1. You have access
      CAR2 Displays Unique Ligand Binding and RXRα Heterodimerization Characteristics
      Scott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. Omiecinski
      Drug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641

P

  1. Picard, Nicolas

    1. You have access
      Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5
      Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre Marquet
      Drug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
  2. Pollack, Gary M.

    1. You have access
      Pharmacokinetics and Pharmacodynamics of Alfentanil in P-Glycoprotein-Competent and P-Glycoprotein-Deficient Mice: P-Glycoprotein Efflux Alters Alfentanil Brain Disposition and Antinociception
      J. Cory Kalvass, Emily R. Olson and Gary M. Pollack
      Drug Metabolism and Disposition March 2007, 35 (3) 455-459; DOI: https://doi.org/10.1124/dmd.106.011445

R

  1. Reisdorph, Richard

    1. You have access
      Constitutive and 3-Methylcholanthrene-Induced Rat ALDH3A1 Expression Is Mediated by Multiple Xenobiotic Response Elements
      Richard Reisdorph and Ronald Lindahl
      Drug Metabolism and Disposition March 2007, 35 (3) 386-393; DOI: https://doi.org/10.1124/dmd.106.012393
  2. Remmel, Rory P.

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  3. Riley, Robert J.

    1. You have access
      The Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery Setting
      Charles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. Riley
      Drug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
  4. Ritter, Joseph K.

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
    2. You have access
      Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
      Stephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
  5. Rostami-Hodjegan, Amin

    1. You have access
      Misuse of the Well-Stirred Model of Hepatic Drug Clearance
      Jiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. Tucker
      Drug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359

S

  1. Sakai, Haruko

    1. You have access
      CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline
      Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
      Drug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
  2. Sauvage, François-Ludovic

    1. You have access
      Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5
      Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre Marquet
      Drug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
  3. Senekeo-Effenberger, Kathy

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  4. Shimizu, Makiko

    1. You have access
      Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation Activities
      Makiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi Yamazaki
      Drug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
  5. Shimomura, Hitoshi

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  6. Slee, Dean

    1. You have access
      The Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery Setting
      Charles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. Riley
      Drug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
  7. Slitt, Angela L.

    1. You have access
      Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis
      Andrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. Cherrington
      Drug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
  8. Smith, Philip C.

    1. You have access
      UDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme Kinetics
      Zhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
    2. You have access
      Glucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species Differences
      Zhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
    3. You have access
      Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
      Stephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
  9. Stern, Stephan T.

    1. You have access
      Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
      Stephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
  10. Stoner, Matthew A.

    1. You have access
      CAR2 Displays Unique Ligand Binding and RXRα Heterodimerization Characteristics
      Scott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. Omiecinski
      Drug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641
  11. Sugiyama, Yuichi

    1. You have access
      Characterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in Rodents
      Kazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518

T

  1. Tallman, Melanie N.

    1. You have access
      UDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme Kinetics
      Zhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
    2. You have access
      Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
      Stephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
  2. Tamai, Ikumi

    1. You have access
      Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines
      Tomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi Tamai
      Drug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
  3. Tanaka, Kanako

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  4. Theile, Dirk

    1. You have access
      Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors
      Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil Haefeli
      Drug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
  5. Torimoto, Nao

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  6. Toyama, Ken-Ichi

    1. You have access
      Helices F–G Are Important for the Substrate Specificities of CYP3A7
      Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  7. Treadway, Judith L.

    1. You have access
      Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors
      Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
      Drug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
  8. Trottier, Jocelyn

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  9. Tsuji, Akira

    1. You have access
      Functional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1
      Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira Tsuji
      Drug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
  10. Tucker, Geoffrey T.

    1. You have access
      Misuse of the Well-Stirred Model of Hepatic Drug Clearance
      Jiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. Tucker
      Drug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
  11. Tukey, Robert H.

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243

W

  1. Watanabe, Tanya A.

    1. You have access
      Cross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100
      Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. Geary
      Drug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
  2. Weiss, Johanna

    1. You have access
      Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors
      Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil Haefeli
      Drug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
  3. Wen, Zhiming

    1. You have access
      UDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme Kinetics
      Zhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
    2. You have access
      Glucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species Differences
      Zhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. Smith
      Drug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815

X

  1. Xiang-Jun, Zhou

    1. You have access
      Inhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious Rats
      Xin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-Xiang
      Drug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429

Y

  1. Yamamoto, Akitoshi

    1. You have access
      Involvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver Microsomes
      Takuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori Momose
      Drug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
  2. Yamazaki, Hiroshi

    1. You have access
      Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation Activities
      Makiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi Yamazaki
      Drug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
  3. Yan-Fei, Xin

    1. You have access
      Inhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious Rats
      Xin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-Xiang
      Drug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429
  4. Yang, Jiansong

    1. You have access
      Misuse of the Well-Stirred Model of Hepatic Drug Clearance
      Jiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. Tucker
      Drug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
  5. Yano, Hiroshi

    1. You have access
      Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation Activities
      Makiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi Yamazaki
      Drug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
  6. Yeo, Karen R.

    1. You have access
      Misuse of the Well-Stirred Model of Hepatic Drug Clearance
      Jiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. Tucker
      Drug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
  7. Yokoi, Tsuyoshi

    1. You have access
      CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline
      Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
      Drug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
  8. Yong-Xiang, Wang

    1. You have access
      Inhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious Rats
      Xin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-Xiang
      Drug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429
  9. Yu, Rosie Z.

    1. You have access
      Cross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100
      Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. Geary
      Drug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
  10. Yueh, Mei-Fei

    1. You have access
      Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
      Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
      Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243

Z

  1. Zhang, Jun

    1. You have access
      Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation Activities
      Makiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi Yamazaki
      Drug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 35 (3)
Drug Metabolism and Disposition
Vol. 35, Issue 3
1 Mar 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics